GreenLight Biosciences (NASDAQ:GRNA), which combined with Environmental Impact in February 2022, announced this morning that it is being acquired in a go-private transaction by Fall Line Capital for $45.5 million.
While this is a steep valuation decline from its $1.23 billion enterprise value at the announcement of its SPAC deal, this price does represent a 50% premium to GreenLight’s last closing price.
Shareholders owning 79.5% of GreenLight’s outstanding equity have agreed to exchange shares for Series A-2 preferred stock in a new holding company that will own the group. The company is also to receive $15 million in cash and issue $15 million in unsecured notes for working capital purposes.
Fall Line aims to supplement this with sales of $100 million in convertible secured promissory notes in the company to further fund it at close and has gathered about $52 million of this amount so far.
GreenLight, which is developing RNA-based vaccines for human health and agricultural crop protection, previewed the deal in its May 11 earnings release, noting that it received an indication of interest from Fall Line in March.
That news was accompanied with results showing that the company’s cash reserves were depleting rapidly to $32.4 million as of the end of the first quarter, down from $68.1 million in December. It predicted that this would be enough to get it through the second quarter, but some other move would be required to extend its runway thereafter.
This was the tail end of GreenLight’s SPAC proceeds, which included a $124 million PIPE. But, the company’s high R&D costs, coupled with just $3.8 million in revenue in the first quarter coming from collaborations have left it on an unsustainable path.
Fortunately, its existing backers are still believers. Fall Line was an investor in its PIPE, and it own investment portfolio is made up of farmland it manages and technology companies it views as strategic to those farms’ success.
As such, GreenLight will be able to continue its work from a private position over the medium term. And, should it regain its footing, it may have the chance at another to back to the public markets in a climate more supportive to early tech ventures.


Terms Tracker for the Week Ending July 11, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. One more IPO priced this week bringing July’s total to 8. However, there are still three more weeks left in the month so that number...
At the SPAC of Dawn Lately de-SPACs have been announcing corporate moves of a kind frequently in trios as was the case earlier this week when WeBull (NASDAQ:BULL), AST SpaceMobile (NASDAQ:ASTS) and Quantum-Si (NASDAQ:QSI) all announced major equity raises. This week, it is a trio of de-SPACs making reverse stock splits in unison, which is...
A look at Plus’ software-first approach to autonomous trucking. After years of investment and excitement, the dawn of self-driving cars and trucks is now here. The question now is which business model among autonomous driving technology companies will win out? This week, we speak with David Liu, CEO of autonomous trucking company Plus. Plus announced...
At the SPAC of Dawn One thing that SPAC investors can typically count on while their money is invested in a SPAC’s trust is that it is going to grow one way or the other between now and their next redemption opportunity, but the devil can occasionally be in the details. In 2024, it became...
Thunderstone has filed for a $50 million SPAC to put a new first-time Asia-based team in action on a generalist hunt. The new SPAC is offering investors a right to a 1/8 share in each unit with 18 months to initially complete a business combination. It is the 8th fresh S-1 filed with underwriter D....